Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34596
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUsta, Mehmet-
dc.date.accessioned2023-10-26T11:37:11Z-
dc.date.available2023-10-26T11:37:11Z-
dc.date.issued2020-06-
dc.identifier.citationUsta, M. vd. (2020). "The relationship between lymphocyte subsets, nutritional status and tuberculin reactivity in continuous ambulatory peritoneal dialysis and hemodialysis patients". International Urology and Nephrology, 52(6), 1167-1172.en_US
dc.identifier.issn0301-1623-
dc.identifier.issn1573-2584-
dc.identifier.urihttps://doi.org/10.1007/s11255-020-02467-1-
dc.identifier.urihttps://link.springer.com/article/10.1007/s11255-020-02467-1-
dc.identifier.urihttp://hdl.handle.net/11452/34596-
dc.description.abstractAim Skin test anergy is common in patients with uremia and during maintenance hemodialysis treatment. However, up to date only one study concerning skin test in peritoneal dialysis patients has focused on the issue. Our cross-sectional controlled study was conducted to analyze the correlation of purified protein derivative (PPD) test response with demographical features, nutritional parameters and the distribution of peripheral blood lymphocyte subsets in peritoneal dialysis and hemodialysis patients Patients and methods Stable 30 hemodialysis (HD) patients (16 men, 14 women) and 30 continuous ambulatory peritoneal dialysis (PD) patients (17 men, 13 women) were included. Thirty healthy cases (15 men, 15 women) with a mean age of 32.4 +/- 9.4 constituted the control group. Results In the HD group, 14 patients (46.6%) were PPD positive, and in the PD group 16 patients (53.3%) were PPD positive. In the PPD-positive HD patients 64.2% (9/14), and in the PPD-positive PD patients 62.4% (10/16) had an induration of 10 mm or greater. In the control group, 21 of 30 patients (70%) were PPD positive. Comparison of both HD and PD groups with the control group showed significant differences in PPD reactivity (p < 0.01). Albumin levels were significantly high in the control groups (p < 0.01), and cholesterol levels were significantly high in the PD and the control groups (p < 0.05). Transferrin levels were significantly high in the PD (p < 0.01). The lymphocyte counts were significantly high in the control group compared to the HD patients (p < 0.05). The lymphocyte subset percentages CD19 were high in the control groups (p < 0.05), and CD16/56 was significantly high in the PD groups (p < 0.05). All the parameters were also similar between PPD-positive and -negative same groups. Conclusion The prevalence of PPD positivity was lower in the PD and HD groups. The PPD test responses were not related to the peripheral lymphocyte counts, subsets and malnutrition parameters.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectUrology & nephrologyen_US
dc.subjectHemodialysisen_US
dc.subjectContinuous ambulatory peritoneal dialysisen_US
dc.subjectTuberculin testingen_US
dc.subjectHuman erythropoietinen_US
dc.subjectNutritional statusen_US
dc.subjectLatent tuberculosisen_US
dc.subjectQuantitative-analysisen_US
dc.subjectInfectionen_US
dc.subjectDiseaseen_US
dc.subject.meshAdulten_US
dc.subject.meshCorrelation of dataen_US
dc.subject.meshCross-sectional studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney failure, chronicen_US
dc.subject.meshLymphocyte subsetsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNutritional statusen_US
dc.subject.meshPeritoneal dialysis, continuous ambulatoryen_US
dc.subject.meshRenal dialysisen_US
dc.subject.meshTuberculin testen_US
dc.subject.meshYoung adulten_US
dc.titleThe relationship between lymphocyte subsets, nutritional status and tuberculin reactivity in continuous ambulatory peritoneal dialysis and hemodialysis patientsen_US
dc.typeArticleen_US
dc.identifier.wos000528133000001tr_TR
dc.identifier.scopus2-s2.0-85083769779tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve İmmünoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.contributor.orcid0000-0001-7625-9148tr_TR
dc.identifier.startpage1167tr_TR
dc.identifier.endpage1172tr_TR
dc.identifier.volume52tr_TR
dc.identifier.issue6tr_TR
dc.relation.journalInternational Urology and Nephrologyen_US
dc.contributor.buuauthorAlparslan, Ersoy-
dc.contributor.buuauthorAyar, Yavuz-
dc.contributor.buuauthorBudak, Ferah-
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.contributor.researcheridAGF-0767-2022tr_TR
dc.contributor.researcheridF-4657-2014tr_TR
dc.relation.collaborationSanayitr_TR
dc.identifier.pubmed32323130tr_TR
dc.subject.wosUrology & nephrologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid35612977100tr_TR
dc.contributor.scopusid55860143300tr_TR
dc.contributor.scopusid57216531873tr_TR
dc.subject.scopusHemodialysis patient; Interferon gamma release assay; skin testsen_US
dc.subject.emtreeAlbüminen_US
dc.subject.emtreeCD16 antigenen_US
dc.subject.emtreeCD19 antigenen_US
dc.subject.emtreeCD56 antigenen_US
dc.subject.emtreeCholesterolen_US
dc.subject.emtreeTransferrinen_US
dc.subject.emtreeTuberculinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAlbumin blood levelen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCholesterol blood levelen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeContinuous ambulatory peritoneal dialysisen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCross-sectional studyen_US
dc.subject.emtreeDemographyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHemodialysis patienten_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman cellen_US
dc.subject.emtreeInjection site indurationen_US
dc.subject.emtreeLymphocyte counten_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMalnutritionen_US
dc.subject.emtreeNutritional parametersen_US
dc.subject.emtreeNutritional statusen_US
dc.subject.emtreePeripheral lymphocyteen_US
dc.subject.emtreeT lymphocyte subpopulationen_US
dc.subject.emtreeTransferrin blood levelen_US
dc.subject.emtreeTuberculin testen_US
dc.subject.emtreeBlooden_US
dc.subject.emtreeChronic kidney failureen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeHemodialysisen_US
dc.subject.emtreeLymphocyte subpopulationen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreeYoung adulten_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Alparslan_vd_2020.pdf575.42 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons